Employees Retirement System of Texas Purchases Shares of 11,856 Globus Medical, Inc. $GMED

Employees Retirement System of Texas purchased a new position in shares of Globus Medical, Inc. (NYSE:GMED) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 11,856 shares of the medical device company’s stock, valued at approximately $1,035,000.

Other hedge funds have also recently made changes to their positions in the company. William Blair Investment Management LLC increased its holdings in Globus Medical by 17.2% in the third quarter. William Blair Investment Management LLC now owns 2,819,165 shares of the medical device company’s stock worth $161,454,000 after purchasing an additional 414,134 shares in the last quarter. ANTIPODES PARTNERS Ltd grew its position in shares of Globus Medical by 49,020.3% during the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 891,043 shares of the medical device company’s stock worth $51,034,000 after buying an additional 889,229 shares during the period. Foresight Group Ltd Liability Partnership grew its position in shares of Globus Medical by 160.7% during the 3rd quarter. Foresight Group Ltd Liability Partnership now owns 421,541 shares of the medical device company’s stock worth $24,142,000 after buying an additional 259,870 shares during the period. Kingdon Capital Management L.L.C. increased its stake in shares of Globus Medical by 51.6% in the 3rd quarter. Kingdon Capital Management L.L.C. now owns 257,650 shares of the medical device company’s stock valued at $14,756,000 after acquiring an additional 87,650 shares in the last quarter. Finally, Annex Advisory Services LLC bought a new stake in shares of Globus Medical in the 4th quarter valued at $20,572,000. 95.16% of the stock is owned by institutional investors.

Globus Medical Trading Down 2.9%

NYSE GMED opened at $82.60 on Thursday. The company has a fifty day simple moving average of $87.21 and a 200 day simple moving average of $88.47. Globus Medical, Inc. has a 12-month low of $51.79 and a 12-month high of $101.40. The company has a market cap of $11.21 billion, a P/E ratio of 19.21, a PEG ratio of 1.76 and a beta of 1.00.

Globus Medical (NYSE:GMED) last released its quarterly earnings data on Thursday, May 7th. The medical device company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.20. The firm had revenue of $759.85 million for the quarter, compared to the consensus estimate of $740.35 million. Globus Medical had a net margin of 18.92% and a return on equity of 13.46%. The business’s revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.68 earnings per share. Globus Medical has set its FY 2026 guidance at 4.700-4.800 EPS. Sell-side analysts predict that Globus Medical, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

GMED has been the topic of several research analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Globus Medical in a research note on Wednesday, April 15th. Barclays upped their price objective on shares of Globus Medical from $118.00 to $123.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Wall Street Zen cut shares of Globus Medical from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Zacks Research upgraded Globus Medical from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 3rd. Finally, Wells Fargo & Company decreased their target price on Globus Medical from $104.00 to $103.00 and set an “overweight” rating for the company in a research report on Friday, May 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $106.36.

About Globus Medical

Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.